325 related articles for article (PubMed ID: 30590491)
1. Systematic Review and Meta-analysis of Chickenpox Vaccination and Risk of Herpes Zoster: A Quantitative View on the "Exogenous Boosting Hypothesis".
Harder T; Siedler A
Clin Infect Dis; 2019 Sep; 69(8):1329-1338. PubMed ID: 30590491
[TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
3. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
Harpaz R; van Hoek AJ
J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
[TBL] [Abstract][Full Text] [Related]
4. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
Goldman GS; King PG
Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster in the context of varicella vaccination - An equation with several variables.
Wutzler P; Casabona G; Cnops J; Akpo EIH; Safadi MAP
Vaccine; 2018 Nov; 36(46):7072-7082. PubMed ID: 30309745
[TBL] [Abstract][Full Text] [Related]
7. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.
Ogunjimi B; Van Damme P; Beutels P
PLoS One; 2013; 8(6):e66485. PubMed ID: 23805224
[TBL] [Abstract][Full Text] [Related]
8. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
9. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.
Wolfson LJ; Daniels VJ; Altland A; Black W; Huang W; Ou W
Clin Infect Dis; 2020 Mar; 70(6):995-1002. PubMed ID: 31147680
[TBL] [Abstract][Full Text] [Related]
11. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
Guzzetta G; Poletti P; Merler S; Manfredi P
Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
[TBL] [Abstract][Full Text] [Related]
12. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
[TBL] [Abstract][Full Text] [Related]
13. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
[TBL] [Abstract][Full Text] [Related]
14. Understanding the role of exogenous boosting in modeling varicella vaccination.
Talbird SE; La EM; Mauskopf J; Altland A; Daniels V; Wolfson LJ
Expert Rev Vaccines; 2018 Nov; 17(11):1021-1035. PubMed ID: 30354696
[TBL] [Abstract][Full Text] [Related]
15. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
17. Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
Widgren K; Tomba GS; Leung KY; Giesecke J
Vaccine; 2022 Jan; 40(4):673-681. PubMed ID: 34930603
[TBL] [Abstract][Full Text] [Related]
18. Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
Bilcke J; van Hoek AJ; Beutels P
Hum Vaccin Immunother; 2013 Apr; 9(4):812-22. PubMed ID: 23321955
[TBL] [Abstract][Full Text] [Related]
19. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
